Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Puerto Rico Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20091
20111
20133
20151
20191
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer2
AstraZeneca1
Brigham and Women's Hospital1
Cogentus Pharmaceuticals1
National Institute of Allergy and Infectious Diseases (NIAID)1
Takeda1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction12
Stroke9
Cardiovascular Diseases7
Acute Coronary Syndrome3
Coronary Artery Disease3
Hyperlipidemias3
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Angina, Unstable1
Atherosclerosis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.